Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Open-label, Single Arm Pilot Study Evaluating the Effect on Virological Response of the Switch From Tacrolimus to Cyclosporin Associated With a Peginterferon Alfa-2a / Ribavirin Bitherapy, in Non-responder or With Recurrent VHC+ Disease Liver Transplanted Patients.

NCT00375895 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT00375895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00375895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Open-label, Single Arm Pilot Study Evaluating the Effect on Virological Response of the Switch From Tacrolimus to Cyclosporin Associated With a Peginterferon Alfa-2a / Ribavirin Bitherapy, in Non-responder or With Recurrent VHC+ Disease Liver Transplanted Patients.
Lead sponsor
Rennes University Hospital
Phase
Phase 3
Overall status
Terminated
Start date
June 30, 2006
Completion date
December 31, 2009
Enrollment
11 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c, evidence of liver transplantation